Potential influence of more-sensitive HIV-1 load detection by the new Roche Cobas AmpliPrep/Cobas TaqMan version 2.0 assay on clinical management of HIV-positive pregnant women

J Clin Microbiol. 2010 Nov;48(11):4301-2. doi: 10.1128/JCM.00598-10. Epub 2010 Sep 8.

Abstract

With the introduction of the new Roche Cobas AmpliPrep/Cobas TaqMan version 2.0 assay, HIV-1 viral loads will be detected more frequently during the peripartum period in pregnant HIV-positive women. The implications for the clinical management of these patients are discussed in this paper.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • HIV Infections / diagnosis*
  • HIV Infections / drug therapy
  • HIV Infections / virology*
  • HIV-1 / isolation & purification*
  • Humans
  • Molecular Diagnostic Techniques / methods
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis*
  • Pregnancy Complications, Infectious / virology*
  • Pregnant Women
  • Reagent Kits, Diagnostic*
  • Viral Load / methods*

Substances

  • Reagent Kits, Diagnostic